Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

    Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L.

    Diabetes Care. 2009 Feb;32(2):281-6. Epub 2008 Nov 18.PMID: 19017778 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.

    Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA.

    Diabetes Care. 2008 Aug;31(8):1650-5. Epub 2008 May 16.PMID: 18487478 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    What is the best predictor of future type 2 diabetes?

    Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M.

    Diabetes Care. 2007 Jun;30(6):1544-8. Epub 2007 Mar 23.PMID: 17384342 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.

    Chou P, Li CL, Wu GS, Tsai ST.

    Diabetes Care. 1998 Jul;21(7):1183-7.PMID: 9653617 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

    McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):758-63.PMID: 12610034 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

    Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

    Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

    de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    JAMA. 2001 Apr 25;285(16):2109-13.PMID: 11311100 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study.

    Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, Kambe H.

    Diabetes Care. 2009 Apr;32(4):644-6. Epub 2009 Jan 8.PMID: 19131461 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

    Stern MP, Williams K, Haffner SM.

    Ann Intern Med. 2002 Apr 16;136(8):575-81.PMID: 11955025 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects.

    Robles-Osorio L, Aguilar-Salinas CA, Mehta R, Gómez-Pérez FJ, Rull JA.

    Endocr Pract. 2007 Oct;13(6):583-9.PMID: 17954413 [PubMed - indexed for MEDLINE]Related articles

    14.

    Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.

    Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD.

    Metabolism. 2008 Mar;57(3):399-403.PMID: 18249214 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.

    Haeckel R, Raber R, Wosniok W.

    Clin Chem Lab Med. 2006;44(12):1462-71. Erratum in: Clin Chem Lab Med. 2007;45(2):276. PMID: 17163824 [PubMed - indexed for MEDLINE]Related articles

    16.

    A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

    Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

    J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491. PMID: 16918824 [PubMed - indexed for MEDLINE]Related articles

    18.

    Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

    Motala AA, Omar MA, Gouws E.

    Diabetes Care. 1997 Jul;20(7):1101-7.PMID: 9203444 [PubMed - indexed for MEDLINE]Related articles

    19.

    [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital]

    Ryu S, Chang YS, Kim DI, Suh BS, Kim WS.

    J Prev Med Public Health. 2005 May;38(2):203-7. Korean. PMID: 16315759 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Ethn Dis. 2002 Fall;12(4):S3-10-7.PMID: 12477148 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data